Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

323 ARTÍCULOS , VIENDO DEL 226 AL 240

Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review

Arevalo-Rodriguez I, Pedraza OL, Rodríguez A, Sánchez E, Gich I, Solà I, Bonfill X, Alonso-Coello P.

Am J Alzheimers Dis Other Demen. 2013 Mar;28(2):111-9. doi: 10.1177/1533317512470209. Epub 2013 Jan 2.

Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection

Risacher SL, Saykin AJ.

Annu Rev Clin Psychol. 2013;9:621-48. doi: 10.1146/annurev-clinpsy-050212-185535. Epub 2013 Jan 7.

Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers

Kosicek M, Hecimovic S.

Int J Mol Sci. 2013 Jan 10;14(1):1310-22. doi: 10.3390/ijms14011310.

Plasma proteomics for the identification of Alzheimer disease

Guo LH, Alexopoulos P, Wagenpfeil S, Kurz A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2013 Oct-Dec;27(4):337-42. doi: 10.1097/WAD.0b013e31827b60d2.

A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease

Peters KR, Lynn Beattie B, Feldman HH, Illes J.

Prog Neurobiol. 2013 Nov;110:114-23. doi: 10.1016/j.pneurobio.2012.12.001. Epub 2013 Jan 21.

State of the science: use of biomarkers and imaging in diagnosis and management of Alzheimer disease

Fraller DB.

J Neurosci Nurs. 2013 Apr;45(2):63-70. doi: 10.1097/JNN.0b013e3182829024.

Alzheimer disease biomarkers and insights into mild cognitive impairment

Knopman DS.

Neurology. 2013 Mar 12;80(11):978-80. doi: 10.1212/WNL.0b013e31828728ac. Epub 2013 Feb 6.

Imaging epigenetics in Alzheimer's disease

Lista S, Garaci FG, Toschi N, Hampel H.

Curr Pharm Des. 2013;19(36):6393-415. doi: 10.2174/13816128113199990370.

[Posterior variant of Alzheimer's disease and other atypical symptom pictures]

Remes AM, Vanninen R, Jokinen H, Hallikainen M, Erkinjuntti T.

Duodecim. 2013;129(3):244-50.

Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease

Leclerc B, Abulrob A.

ScientificWorldJournal. 2013;2013:589308. doi: 10.1155/2013/589308. Epub 2013 Feb 5.

The role of cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis. where are we now?

Papaliagkas VT.

Recent Pat CNS Drug Discov. 2013 Apr;8(1):70-8. doi: 10.2174/1574889811308010006.

Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria

Sperling R, Johnson K.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):325-38. doi: 10.1212/01.CON.0000429181.60095.99.

Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process

Stefani A, Olivola E, Stampanoni Bassi M, Pisani V, Imbriani P, Pisani A, Pierantozzi M.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):538-46. doi: 10.2174/1871527311312040016.

Smell identification function as a severity and progression marker in Alzheimer's disease

Velayudhan L, Pritchard M, Powell JF, Proitsi P, Lovestone S.

Int Psychogeriatr. 2013 Jul;25(7):1157-66. doi: 10.1017/S1041610213000446. Epub 2013 Apr 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias